DE69813845D1 - Neue plasmid-dns, die ein reportergen enthält, und ihre verwendung. - Google Patents

Neue plasmid-dns, die ein reportergen enthält, und ihre verwendung.

Info

Publication number
DE69813845D1
DE69813845D1 DE69813845T DE69813845T DE69813845D1 DE 69813845 D1 DE69813845 D1 DE 69813845D1 DE 69813845 T DE69813845 T DE 69813845T DE 69813845 T DE69813845 T DE 69813845T DE 69813845 D1 DE69813845 D1 DE 69813845D1
Authority
DE
Germany
Prior art keywords
plasmid dna
reportergen
dna containing
new plasmid
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69813845T
Other languages
English (en)
Other versions
DE69813845T2 (de
Inventor
Hiroshi Hagiya
Masashi Minami
Hisao Tajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of DE69813845D1 publication Critical patent/DE69813845D1/de
Application granted granted Critical
Publication of DE69813845T2 publication Critical patent/DE69813845T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
DE69813845T 1997-06-27 1998-06-23 Neue plasmid-dns, die ein reportergen enthält, und ihre verwendung. Expired - Fee Related DE69813845T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17144097 1997-06-27
PCT/JP1998/002785 WO1999000491A1 (fr) 1997-06-27 1998-06-23 Nouvel adn plasmidique contenant de l'adn de gene reporter et utilisation associee

Publications (2)

Publication Number Publication Date
DE69813845D1 true DE69813845D1 (de) 2003-05-28
DE69813845T2 DE69813845T2 (de) 2003-12-24

Family

ID=15923168

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69813845T Expired - Fee Related DE69813845T2 (de) 1997-06-27 1998-06-23 Neue plasmid-dns, die ein reportergen enthält, und ihre verwendung.

Country Status (11)

Country Link
US (2) US6855543B1 (de)
EP (1) EP1016714B1 (de)
JP (1) JP4044969B2 (de)
KR (1) KR20010014218A (de)
AT (1) ATE238416T1 (de)
AU (1) AU8038698A (de)
DE (1) DE69813845T2 (de)
DK (1) DK1016714T3 (de)
ES (1) ES2197475T3 (de)
PT (1) PT1016714E (de)
WO (1) WO1999000491A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9917405D0 (en) * 1999-07-23 1999-09-22 Univ Dundee Methods of treatment and drug screening methods
JP4632481B2 (ja) * 2000-05-22 2011-02-16 忠 田邉 プロスタサイクリン合成酵素遺伝子含有医薬組成物
JP2008538351A (ja) 2005-03-21 2008-10-23 メタボレックス インコーポレーティッド 癌を含むＰＰＡＲγ反応性疾患の処置または予防における浮腫を回避するための方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU696991B2 (en) * 1993-07-16 1998-09-24 Board Of Trustees Of The Leland Stanford Junior University Regulated apoptosis
EP0743520A3 (de) 1993-12-30 1999-11-10 The Salk Institute For Biological Studies Neue Verwendungen von Gal4-Rezeptor-Konstruktionen
JP3700791B2 (ja) * 1994-05-26 2005-09-28 小野薬品工業株式会社 Ｆａｓ抗原融合蛋白、その蛋白をコードするＤＮＡ、そのＤＮＡを含むベクター、そのベクターで形質転換された宿主細胞、そのベクターを有効成分とする治療剤、およびその宿主細胞を用いるスクリーニング方法
IL114615A0 (en) * 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
US5939442A (en) * 1995-06-07 1999-08-17 The Salk Institute For Biological Studies Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof
US5972899A (en) * 1996-01-25 1999-10-26 New York University Apoptosis induced by Shigella IpaB
US7442776B2 (en) * 1999-10-08 2008-10-28 Young David S F Cancerous disease modifying antibodies

Also Published As

Publication number Publication date
ES2197475T3 (es) 2004-01-01
US6855543B1 (en) 2005-02-15
ATE238416T1 (de) 2003-05-15
EP1016714A1 (de) 2000-07-05
JP4044969B2 (ja) 2008-02-06
AU8038698A (en) 1999-01-19
WO1999000491A1 (fr) 1999-01-07
EP1016714A4 (de) 2000-09-20
KR20010014218A (ko) 2001-02-26
DK1016714T3 (da) 2003-08-11
EP1016714B1 (de) 2003-04-23
DE69813845T2 (de) 2003-12-24
PT1016714E (pt) 2003-09-30
US20050158775A1 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
AU2560599A (en) Diagnosis and treatment of aur1 and/or aur2 related disorders
CA2171638A1 (en) The semaphorin gene family
IL124728A0 (en) Diagnosis and treatment of aur-1 and/or aur-2 related disorders
WO1999058675A3 (en) Human genes and gene expression products v
CA2295999A1 (en) Nik proteins, nucleic acids and methods
PL336635A1 (en) Proteins of human tool-like receptor and their associated reagents and methods
DE69535641D1 (de) Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
ATE342358T1 (de) Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen
WO2001064877A3 (en) Human schizophrenia gene
CA2064814A1 (en) Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
DE69813845T2 (de) Neue plasmid-dns, die ein reportergen enthält, und ihre verwendung.
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
WO2001064713A3 (en) Mammalian interleukin-10 (il-10) receptor variants
EP0990703A4 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
EP1655382A3 (de) Dickdarm spezifisches Gen und Protein
WO2001064876A3 (en) Human schizophrenia gene
WO2000040722A3 (en) Insulin-synthesis genes
EP0854186A3 (de) Zellteilungs-Gen DivIB von Staphylococcus aureus
ATE294861T1 (de) Polypeptide mit opioider rezeptor-aktvität, für sie kodierende nukleinsäuren und ihre verwendungen
WO1998041538A3 (en) Novel human cytokine/steroid receptor protein
WO2002006479A3 (de) Apoptose-induzierende dna-sequenzen
WO2001029178A3 (en) Epo primary response gene 1, eprg1
EP0885903A3 (de) Nukleinsäure kodierend für Streptococcus pneumoniae Response-Regulator
WO1999019491A3 (en) Human dnax interleukin-40 (dil-40)
AU4494599A (en) Method for genetic engineering of disease resistance using the drr206 class of proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee